ÂÜÀòÂÒÂ×

Victoria-Elisabeth Gruber is a highly experienced researcher currently serving as the Head of Translational Research at Frontier Bio since August 2022, where responsibilities include establishing a biology lab and developing innovative 3D in vitro technologies for drug development. Previous roles include Senior Scientist at Harvard Medical School and Postdoctoral Scientist at the Medical University of Vienna, focusing on epilepsy-related brain lesions and regenerative medicine. Victoria-Elisabeth possesses extensive expertise in various laboratory techniques and has a strong background in biomarker research and personalized medicine. Educational qualifications include a PhD in Clinical Neurosciences, a Master's in Biochemistry, and a Bachelor's degree in Biomedical Sciences, complemented by a project management diploma.